Invus Global Management, LLC - 16 Mar 2026 SCHEDULE 13G Report for Olema Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (OLMA)

Filing Manager: Invus Global Management, LLC
Reporting Manager: Raymond Debbane
Security: Olema Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share
Symbol: OLMA
Shares outstanding: 87,489,196 shares
Disclosed Ownership: 4,461,949 shares
Ownership: 5.1%
Form type: SCHEDULE 13G
Filing time: 20 Mar 2026, 10:37:43 UTC
Date of event: 16 Mar 2026
SEC: View on sec.gov

Reporting Managers (8)

Name	Ownership	Shares Owned	sole voting power	Signature	Title
Invus Public Equities, L.P.	4.5%	3,898,500	3,898,500	/s/ Raymond Debbane	Raymond Debbane, President of Invus Public Equities Advisors, LLC, its general partner
Invus Public Equities Advisors, LLC	4.5%	3,898,500	3,898,500	/s/ Raymond Debbane	Raymond Debbane, President
Invus Global Management, LLC	4.5%	3,898,500	3,898,500	/s/ Raymond Debbane	Raymond Debbane, President
Siren, L.L.C.	4.5%	3,898,500	3,898,500	/s/ Raymond Debbane	Raymond Debbane, President
Avicenna Life Sci Master Fund LP	0.6%	563,449	563,449	/s/ Raymond Debbane	Raymond Debbane, Chief Executive Officer of Avicenna Life Sci Master GP LLC, its general partner
Avicenna Life Sci Master GP LLC	0.6%	563,449	563,449	/s/ Raymond Debbane	Raymond Debbane, Chief Executive Officer
Ulys, L.L.C.	0.6%	563,449	563,449	/s/ Raymond Debbane	Raymond Debbane, President
Raymond Debbane	5.1%	4,461,949	4,461,949	/s/ Raymond Debbane	Raymond Debbane